Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Latent Tuberculosis Infection (LTBI) Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Latent Tuberculosis Infection (LTBI) Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Tuberculin Skin Test (TST) Interferon Gamma Released Assay (IGRA) Segmented by End User/Segment Hospitals and Clinics Diagnostic Laboratories Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Thermo Fisher Scientific Sanofi Qiagen Par Sterile Oxford Immunotec Bio-Rad Laboratories

List of Tables

Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Company (2019-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Area
Table Latent Tuberculosis Infection (LTBI) Testing Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sals Value Market Share by Category (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Category (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Category (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Category (2016-2021)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table Central & South America Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Category (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Category (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by Category (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value Market Share by End User/Segment (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Central & South America Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by End User/Segment (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Sales Value Market Share by End User/Segment (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Region (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Region (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Country (2016-2021)
Table North America Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Country (2016-2021)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country (2016-2021)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country (2016-2021)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value (Million USD) Forecast by Category (2022-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value Market Share Forecast by Category (2022-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value (Million USD) Forecast by End User/Segment (2022-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value Market Share Forecast by End User/Segment (2022-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value (Million USD) Forecast by Region (2022-2027)
Table Global Latent Tuberculosis Infection (LTBI) Testing Value Market Share Forecast by Region (2022-2027)
Table Thermo Fisher Scientific Company Information
Table Thermo Fisher Scientific Product Introduction
Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Sanofi Company Information
Table Sanofi Product Introduction
Table Sanofi Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Qiagen Company Information
Table Qiagen Product Introduction
Table Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Par Sterile Company Information
Table Par Sterile Product Introduction
Table Par Sterile Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Oxford Immunotec Company Information
Table Oxford Immunotec Product Introduction
Table Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Bio-Rad Laboratories Company Information
Table Bio-Rad Laboratories Product Introduction
Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Status and Forecast (2016-2027) 1.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Latent Tuberculosis Infection (LTBI) Testing Supply by Company 2.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales Value by Company 2.2 Latent Tuberculosis Infection (LTBI) Testing Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Latent Tuberculosis Infection (LTBI) Testing Market Status by Category 3.1 Latent Tuberculosis Infection (LTBI) Testing Category Introduction 3.1.1 Tuberculin Skin Test (TST) 3.1.2 Interferon Gamma Released Assay (IGRA) 3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Latent Tuberculosis Infection (LTBI) Testing Market Status by End User/Segment 4.1 Latent Tuberculosis Infection (LTBI) Testing Segment by End User/Segment 4.1.1 Hospitals and Clinics 4.1.2 Diagnostic Laboratories 4.1.3 Others 4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Latent Tuberculosis Infection (LTBI) Testing Market Status by Region 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market by Region 5.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Status 5.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Status 5.4 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Status 5.5 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Status 5.6 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Status6 North America Latent Tuberculosis Infection (LTBI) Testing Market Status 6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Latent Tuberculosis Infection (LTBI) Testing Market Status 7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Status 8.1 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Status 9.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Status 10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Category and by End User/Segment 12.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales Value Forecast (2022-2027) 12.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Category 12.3 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by End User/Segment13 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region/Country 13.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Thermo Fisher Scientific 14.1.1 Company Information 14.1.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.1.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Sanofi 14.2.1 Company Information 14.2.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Qiagen 14.3.1 Company Information 14.3.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.3.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Par Sterile 14.4.1 Company Information 14.4.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.4.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Oxford Immunotec 14.5.1 Company Information 14.5.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.5.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Bio-Rad Laboratories 14.6.1 Company Information 14.6.2 Latent Tuberculosis Infection (LTBI) Testing Product Introduction 14.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis ...15 Conclusion16 Methodology